New Key Statistics Module, Z-Score and F-Score
NAS:HBIO Key Ratios
| Market Cap $ M | 101.61 |
| Enterprise Value $ M | 142.07 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 15.54 |
| Price/Book | 1.51 |
| Price/Sales | 1.00 |
| Price/Free Cash Flow | 16.32 |
| Price/Owner Earnings | 61.32 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 101.00 |
| EPS (TTM) $ | -0.25 |
| Beneish M-Score | -3.44 |
| 10-y EBITDA Growth Rate % | -1.80 |
| 5-y EBITDA Growth Rate % | -12.40 |
| y-y EBITDA Growth Rate % | -79.60 |
| EV-to-EBIT | -22.72 |
| EV-to-EBITDA | 160.53 |
| PEG | -- |
| Shares Outstanding M | 43.61 |
| Net Margin (%) | -10.56 |
| Operating Margin % | -4.70 |
| Pre-tax Margin (%) | -9.32 |
| Quick Ratio | 0.94 |
| Current Ratio | 2.05 |
| ROA % (ttm) | -7.83 |
| ROE % (ttm) | -14.88 |
| ROIC % (ttm) | -4.26 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.20 |
HBIO Number of Guru Trades
HBIO Volume of Guru Trades
Gurus Latest Trades with NAS:HBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HBIO is held by these investors
Total 1
Harvard Bioscience Inc Insider Transactions
No Available Data
News about NAS:HBIO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers